Available Online: Non-Dilutive Funding Opportunities for Cancer R&D

 

NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle, from basic research, through pre-clinical activities and early phase clinical trials.

In this webinar, we discuss key cancer related opportunities, focusing on the new set of solicitations from the National Cancer Institute (NCI) and the soon to be released CDMRPs (DoD) that are available for life science organizations.

 

View Slide Deck

/0 Comments/by
You might also like
How will Congress' $1.5 Trillion Allocations Bill affect Biotech, Medtech, Health-tech, and biopharmaWebinar Introducing the SBIR and STTR Funding Opportunities Available Online!
AN INTRO TO SBIR
immuno-oncology innovation forum, May 24-25, 2022, by Sachs AssociatesImmuno-Oncology Innovation Forum, May 24-25, 2022 (online)
Get 10% off Sachs Associates' 9th Annual Immuno-Oncology Innovation Forum #Sachs_IOIF, June 2, at the Waldorf Astoria Chicago. The programme is designed to discuss key industry trends and milestones on the eve of the ASCO meeting. The event brings together leaders from cancer research institutes, patient advocacy groups, pharma and biotech, and Wall Street, to facilitate partnering, funding and investment. We anticipate around 250 delegates and 25+ company presentations by established and emerging companies with part of the audience participating virtually. We've secured a 10% discount on registration for members of our network. (Just say you're with FreeMind when you register.) There's also a limited number of complimentary passes for qualified institutional (buy/sell-side), private equity, and venture investors.Sachs Associates’ 9th Immuno-Oncology Innovation Forum
Research funding opportunities for ALS from CDMRP, and a webinar about how to apply for themALS Research Funding Opportunities from CDMRP in 2022
NIAID BAA January 2022
Available Online: Non-Dilutive Funding Opportunities for Cancer R&D Webinar
How will Congress' $1.5 Trillion Allocations Bill affect Biotech, Medtech, Health-tech, and biopharmaHow will Congress’ $1.5-Trillion Allocations Bill Affect Life Science R&D?
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *